SCHEMBL4353785

SCHEMBL4353785

C=CCc1c(CCCN)c2ccccc2oc1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VKORC1 Q9BQB6 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP2D6 P10635 1/20 0.43
NQO1 P15559 4/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
TP53 P04637 2/20 0.42
TSHR P16473 2/20 0.42
MAPK1 P28482 2/20 0.42
MEN1 O00255 1/20 0.42
ABCB11 O95342 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
KMT2A Q03164 1/20 0.42
PDE4D Q08499 1/20 0.42
PCSK7 Q16549 1/20 0.42
GPR35 Q9HC97 1/20 0.42
KDM4E B2RXH2 2/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27152753 0.85 ESR1 (0.46) VKORC1CYP1A2CYP2C19NQO1ALDH1A1
SCHEMBL5478821 0.79 VKORC1 (0.51) VKORC1CYP1A2CYP2C19NQO1ALDH1A1
SCHEMBL7192591 0.79 GAA (0.57) VKORC1CYP1A2CYP2C19NQO1ALDH1A1
SCHEMBL3988877 0.79 GAA (0.57) VKORC1CYP1A2CYP2C19NQO1ALDH1A1
SCHEMBL7143392 0.76 VKORC1 (0.71) VKORC1CYP1A2CYP2C19NQO1ALDH1A1
SCHEMBL3981987 0.72 VKORC1 (0.45) VKORC1CYP1A2CYP2C19NQO1ALDH1A1
SCHEMBL7140693 0.72 CA12 (0.52) VKORC1CYP1A2CYP2C19NQO1ALDH1A1
SCHEMBL4530526 0.71 SRC (0.52) VKORC1CYP1A2CYP2C19NQO1ALDH1A1
SCHEMBL28455189 0.70 ALDH1A1 (0.47) VKORC1CYP1A2CYP2C19NQO1ALDH1A1
SCHEMBL5677951 0.70 MAOA (0.47) VKORC1CYP1A2CYP2C19NQO1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090005436-A1 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives NEWRON PHARMACEUTICALS S.P.A. (IT) 2009-01-01 US disclosed
CN-101137638-A Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives NEWRON PHARM SPA (IT) 2008-03-05 CN disclosed
EP-1863784-A1 SUBSTITUTED AMINOALKYL- AND AMIDOALKYL-BENZOPYRAN DERIVATIVES Newron Pharmaceuticals S.p.A. (IT) 2007-12-12 EP disclosed
WO-2006102958-A1 SUBSTITUTED AMINOALKYL- AND AMIDOALKYL-BENZOPYRAN DERIVATIVES NEWRON PHARMACEUTICALS S.P.A. (IT) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005436-A1 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives MAOB, MAOA, AOC3 VKORC1 1290/4885CYP1A2 56/4885CYP2C19 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.